Mast cells are a native composer of connective tissue of the skin dermis and intestinal and respiratory mucosa. Independent lines of accumulated evidence indicate the existence of an intensive bidirectional crosstalk between mast cells and sensory nerves and suggest that mast cells and sensory nerves may be viewed as a functional unit, which could be of crucial importance in neuroimmunological pathways. Mast cells appear to have a property of influencing smooth muscle function via not only such nerve-mast cell effects, but also direct pathways. In bronchial asthma, mast cells infiltrate the airway smooth muscle layer, and interact directly with smooth muscle cells, suggesting pathogenic roles for mast cells in airway obstruction. Current studies on mast cell biology identified a novel adhesion molecule of mast cells, namely cell adhesion molecule-1, CADM1. This molecule is unique, because it serves as not only simple glue but also appears to promote functional communication between nerve and mast cells and between smooth muscle and mast cells.
each site of final differentiation (Kitamura, 1989; Chen et al., 2005) . In addition, while most myeloid cells lose proliferation potential after maturation, peripherally resident mature mast cells still retain proliferation potential (Sonoda et al., 1984) . Even after they have executed degranulation, mature mast cells are able not only to proliferate but also to acquire the original morphology by generating cytoplasmic granules (Kuriu et al., 1989; Jozaki et al., 1990) .
What makes mast cells notorious is their function as effecter cells in the immediate hypersensitivity of allergic reactions. Mast cells, as well as basophils, are recognized as causative agents of allergic diseases, such as allergic rhinitis and infantile asthma. However, mast cells are known to play some beneficial roles in the host defense by releasing tumor necrotizing factor alpha (TNFalpha) and other mediators that orchestrate local inflammatory responses (Galli and Wershil, 1996) . When helminthes and ticks infect the intestine and skin, mast cells are activated in an IgE-dependent manner, and they release a variety of mediators (Ruitenberg and Elgersma, 1976; Kojima et al., 1980; Matsuda et al., 1990) . Mast cells are necessary to expel intestinal helminthes and dermal ticks, because mast cell-deficient Kit W /Kit W-v mice cannot do this (Kojima et al., 1980; Matsuda et al., 1990) . (Echtenacher et al., 1996; Malavia et al., 1996) . Mast cells appear to be important for the clearance of bacteria. To fulfill this role, it is essential for mast cells to release TNFalpha in response to contact with a component of the bacteria, because TNFalpha recruits neutrophils into the peritoneal cavity.
Nerve-mast cell interaction mediated by CADM1
As a composer of connective tissue, mast cells exist in various tissues and organs. Their distribution seems to be at random in the skin dermis and intestinal and respiratory mucosa, but with closer observation, one can notice that mast cells prefer to locate around vessels and nerve fibers (Selye, 1965) . In fact, some mast cells are in a close approximation to nerves in connective tissues of various organs. According to electron microscopy, membrane-membrane apposition with a spatial gap of approximately 20 nm or less is detected between nerve and mast cells (Stead et al., 1987; Stead et al., 1989) . These anatomical findings are suggestive of functional communication between nerve and mast cells.
Several lines of molecular events support this suggestion: (1) nerves in contact with mast cells often contain neuropeptides, such as substance P and calcitonin gene-related peptide, and release these neuropeptides on stimulation (Stead et al., 1987; Keller and Marfurt, 1991) , and (2) mast cells express receptors for many neuropeptides (Krumins and Broomfield, 1993; Cooke et al., 1998; van der Kleij et al., 2003; Bischoff et al., 2004; De Jonge et al., 2004) . Therefore, nerve activation results in mast cell activation, i.e., degranulation or secretion of mediators (Dimitriadou et al., 1991) . On the other hand, mast cells synthesize and release a variety of molecules, which can, in turn, influence neuronal activity (Frieling et al., 1991; Frieling et al., 1993) . For example, tryptase directly activates proteinase-activated receptors on neurons (Corvera et al., 1999) , and TNFalpha and nerve growth factor cause changes in local nerves so as to lower their threshold to activation (Leon et al., 1994; van Houwelingen et al., 2002) . These nerve-mast cell effects, together with the anatomical association between both, are assumed to be important for the promotion and regulation of many inflammatory diseases, such as atopic dermatitis, alopecia, asthma, and irritable bowel syndrome (Theoharides, 1996; Barbara et al., 2004; Theoharides and Cochrane, 2004) . In spite of such clinical importance, the molecules that connect mast cells directly with nerves have not been studied intensively so far.
The time was 2003, when we isolated cell adhesion molecule-1, CADM1, as a novel mast cell adhesion molecule (Ito et al., 2003a) , and at the same time we realized that CADM1 is an adhesion molecule common to nerves and mast cells. Structurally, this molecule belongs to the immunoglobulin superfamily, and has 3 immunoglobulin-like motifs in the extracellular domain and a short cytoplasmic domain that interacts with other proteins via the protein 4.1-binding and PDZ-binding motifs (Wakayama et al., 2003;  Fig. 1 ). To date, a variety of cells have been revealed to express CADM1, including epithelial cells, such as pulmonary and biliary epithelial cells (Ito et al., 2003b , Ito et al., 2007b and pancreatic islet cells (Koma et al., in press) , and non-epithelial cells, such as neurons (Biederer et al., 2002) , spermatogenic cells (Wakayama et al., 2003) , and mast cells (Ito et al., 2003a) . CADM1 forms homodimers on the cell membrane through cis- interactions, and binds either trans-homophilically or heterophilically, depending on the cell type expressing the CADM1 and the binding partners available on adjacent cells. The trans-homophilic binding occurs among neurons (Biederer et al., 2002) and among epithelial cells of identical types, and the trans-heterophilic binding occurs between mast cells and fibroblasts (Ito et al., 2003a) and between spermatogenic and Sertoli cells (Wakayama et al., 2007) . Recently, one of the heterophilic binding partners was identified as Class-I-restricted T-cell-associated molecule. In addition to the full-length form of approximately 100 kDa, CADM1 appears to have two shorter forms of about 35 and 15 kDa, which are probably generated by N-terminal truncation of the fulllength form, as suggested in murine mast cells (Ito et al., 2003a) and human mesothelial cells ; however, the function of these truncated forms remains unclear. Formerly, CADM1 was referred to as synaptic cell adhesion molecule (SynCAM), spermatogenic immunoglobulin superfamily (SgIGSF) (Wakayama et al., 2001) , tumor suppressor in lung cancer-1 (TSLC1) (Kuramochi et al., 2001) , nectin-like molecule-2 (Necl-2) (Shingai et al., 2003) , immunoglobulin superfamily 4A (IGSF4A), or retinoic acid-inducible gene 175 (RA175) (Urase et al., 2001) . As might be expected from the variety of names, CADM1 proved to be multifunctional. In a period from 2002 to 2007, several research groups reported CADM1 functions independently. Murakami and coworkers (Kuramochi et al., 2001) found the CADM1 gene in the chromosomal region where lung cancers often exhibit loss of heterozygosity, and identified CADM1 as a tumor suppressor in human non-small lung cancer.
Momoi and coworkers generated CADM1 knockout mice and demonstrated that loss of CADM1 results in male infertility (Fujita et al., 2006) . We found that biliary epithelial cells express CADM1 transiently and showed its possible role in bile duct formation (Ito et al., 2007b) . Of our great interest was the report by Biederer et al. (2002) . They showed that CADM1 is localized on pre-and post-synaptic terminals of neurons in the brain, and functions as a homophilic adhesion molecule that spans the synaptic cleft. More importantly, they demonstrated that synaptic differentiation is induced even in non-neuronal cells at the contact site with neuronal cells when the non-neuronal cells were transfected with CADM1 and glutamate receptor cDNAs. CADM1 appears to assemble machineries necessary for synapse formation around its cytoplasmic domain.
On the other hand, we applied a cDNA library subtraction method to probe molecular mechanisms of mast cell deficiency in mice, which have mutations in the gene locus encoding microphthalmia transcription factor (MITF), a member of the basic-helix-loop-helix-leucine zipper family. Repeated subtraction processes allowed us to isolate CADM1 as a novel mast-cell adhesion molecule whose expression was critically regulated by the MITF (Ito et al., 2003a) . We revealed some roles for CADM1 in mast cell survival (Ito et al., 2004) . CADM1 contributes to efficient attachment of mast cells to fibroblasts, and this attachment appears to result in enhancement in growth-promoting signal transduction into mast cells mediated by binding between membranebound stem cell factor on fibroblasts and c-kit receptor tyrosine kinase on mast cells.
We examined whether CADM1 mediates the attachment between nerves and mast cells via trans-homophilic binding (Furuno et al., 2005) . Bone marrow-derived cultured mast cells (BMMCs) or IC-2 murine mast cells, which lack CADM1 expression, were seeded onto networks of neurites extending out from superior cervical ganglia (SCG), and the number of mast cells attached to the neurites per SCG cell was counted. The attachment of mast cells expressing CADM1, such as wild-type BMMCs, was inhibited dose-dependently by a blocking antibody to CADM1, whereas mast cells lacking CADM1, such as MITF mutant-derived BMMCs and IC-2 cells, were defective in attachment to neurite, and transfection with CADM1 cDNA normalized this (Furuno et al., 2005) . Immunocytochemistry revealed that CADM1 was locally concentrated at points of contact between neurites and mast cells (Furuno et al., 2005) . CADM1 appeared to mediate the adhesion between mast cells and neurites via trans-homophilic binding.
Next, we examined whether CADM1-mediated nerve-mast cell attachment results in efficient communication between both. In SCG neurite-mast cell cocultures, neurites were selectively activated with scorpion venom. Following neurite activation, some of IC-2 cells attendant to neurites became activated with a lag time of approximately 10-20 seconds (Furuno et al., 2005) . This event was considered to be a response of mast cells to neurite activation, because mast cells distant from neurites did not become activated and scorpion venom did not activate mast cells directly. One-quarter of IC-2 cells attendant to neurites responded, whereas CADM1 exogenously expressed in IC-2 cells doubled this proportion. The response of IC-2 cells was blocked by CP-99,994-1, an antagonist to neurokinin-1 receptor, which is receptive for substance P (Furuno et al., 2005) . Notably, a much higher concentration of the antagonist was required to inhibit the response of IC-2 cells expressing CADM1 exogenously (Furuno et al., 2005) . CADM1 appeared not only to function as simple glue in nerve-mast cell interaction, but also to promote the development of microenvironment where mast cells have an enhanced susceptibility to nerve activation.
Homophilic binding of this adhesion molecule might result in an increase in the number of neurokinin-1 receptors on mast cells or in the amount of Substance P released from the neurite. The role of CADM1 in nerve-mast cell interaction was assessed under the conditions nearer in vivo setting (Ito et al., 2007a) . In the rodent mesentery, a microanatomical contact has been demonstrated between mast cells and peptidergic nerves containing substance P (Stead et al., 1989; Arizono et al., 1990; Crivellato et al., 1991) . Therefore, we examined whether activation of mesenteric peptidergic nerves may result in degranulation of mast cells in contact with the nerves. The mesenteric nerve root was stimulated electrically, because it is shown to induce intestinal contraction by evoking efferent function of substance P-ergic sensory nerves in the presence of guanethidine and hexamethonium (Sugimori et al., 2000) . In the steady-state mesentery of wild-type mice, the proportion of morphologically degranulating mast cells was approximately 20%, and it increased nearly two-fold when the mesenteric nerve root was stimulated electrically (Ito et al., 2007a) . In contrast, there was no significant increase detectable in the mesentery of MITF-mutant mice. When CADM1 knockout mouse-derived BMMCs were transplanted to the mesentery of mast cell-deficient Kit W /Kit W-v mice, they did not degranulate in response to the mesenteric nerve stimulation, whereas transfection with CADM1 cDNA restored those responses (Ito et al., 2007a) . CADM1 appeared to promote communication between nerves and mast cells in the murine mesentery.
Possible implication of CADM1-mediated nerve-mast cell interaction in pathophysiology of human diseases
Psychoemotional stressors have long been expected to exacerbate or trigger atopic and allergic diseases, such as atopic dermatitis and bronchial asthma. One of the most intriguing hypotheses for this effect is that stress induces neurogenic inflammation and cytokine production. Currently, Peters and coworkers demonstrated that stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice (Pavlovic et al., 2007) . Maurer and coworkers demonstrated that sensory skin nerves augment mast cell-driven inflammatory responses by releasing neuropeptides that increases mast cell degranulation in a mouse model of passive cutaneous anaphylaxis (Siebenhaar et al., 2008) . Kurebayashi and coworkers attempted to generate 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats, and found that mast cell-deficient Ws/Ws rats did not manifest symptoms of visceral hypersensitivity in this model (Ohashi et al., 2008) . Many independent lines of evidence consistently indicate the existence of an intensive bidirectional crosstalk between mast cells and sensory nerves and suggest that mast cells and sensory nerves may be viewed as a functional unit and that the crosstalk between mast cells and sensory nerves could be of crucial importance in neurogenic inflammation pathways. Clinicians often experience that psychoemotional stress worsens patients' symptoms in a variety of non-infectious inflammatory diseases, such as migraines, atopic dermatitis, bronchial asthma, and irritable bowel syndrome (Theoharides and Cochrane, 2004) . It is noticeable that mast cells are postulated to be involved in the pathophysiology of all these diseases. As these diseases gets worse, the magnitude of nerve-mast cell interaction may grow stronger. In fact, in the intestinal mucosa of patients with irritable bowel syndrome, the number of activated mast cells in close proximity to nerves correlates with severity and frequency of abdominal pain and/or discomfort (Barbara et al., 2004) . Neurogenic inflammation is likely to play a causative role in psychoemotional stress-evoked exacerbation of symptoms, and enhancement in nerve-mast cell interaction is assumed to underlie such pathophysiological conditions. Of our great interest is to examine how psychoemotional stress augments the extent of nerve-mast cell interaction. We are now intensively examining possible molecular linkage between CADM1 expression and psychoemotional stress or inflammatory response.
Smooth muscle-mast cell interaction mediated by CADM1 in asthma
Bronchial asthma is characterised by the presence of variable airflow obstruction, airway hyperresponsiveness and chronic airway inflammation. Mast cells play an important role in the pathophysiology of asthma through their chronic activation by IgE and allergen (Cruse et al., 2005; Bradding et al., 2006) . To fulfil this role, mast cells not only secrete a plethora of bronchospastic and proinflammatory autacoid mediators, proteases and cytokines , but also appear to infiltrate the airway smooth muscle layer (Brightling et al., 2002) , because mast cells neither exist in this layer under physiologic conditions, nor infiltrate the layer of patients with eosinophilic bronchitis (Brightling et al., 2002) , who have high levels of mast cell mediators in their sputum a nd ai rw ay eosinoph ilia, but no bronchial hyperresponsiveness or symptoms of airflow obstruction. Noticeably, the specific infiltration of airway smooth muscle by mast cells is one of the critical determinants of the asthmatic phenotype: (1) mast cell density in the airway smooth muscle layer correlates with the severity of airway hypersenresponsiveness (Brightling et al., 2002) , and (2) the mast cells within the smooth muscle bundles in asthma exhibit ultrastructural features of activation (Begueret et al., 2007) . We recently demonstrated an important role for CADM1 in the specific recruitment of mast cells to airway smooth muscle. Human lung mast cells appeared to adhere to human bronchial smooth muscle cells, in part via CADM1 (Yang et al., 2006) . This action of CADM1 is probably dependent upon its trans-heterophilic binding manner, because smooth muscle cells do not express CADM1. Previously, we showed that trans-heterophilic binding of CADM1 mediates mast cell-fibroblast attachment and this attachment contributes to mast cell survival (Ito et al., 2003a; Ito et al., 2004) . Although it remains unknown what molecule(s) are the transheterophilic binding partner expressed on smooth muscle cells and fibroblasts, it is intriguing to speculate that specific cellular crosstalk occurs between human lung mast cells and airway smooth muscle cells (Fig. 2) . 
Concluding remarks
During the last decade there has been a marked accumulation in the evidence indicating that nerve and mast cells communicate bi-directionally with each other. As we reviewed here, CADM1 is, to our knowledge, the first molecule that has proved to sustain and promote this communication. Importantly, CADM1 is not just simple glue but an enhancer of the communication. Therefore, CADM1 could play a causative role in exacerbation of neurogenic inflammation, if its expression or function is enhanced in response to psychoemotional stress and inflammatory cytokines. As we highlighted in asthma, CADM1 may also be an important mediator between smooth muscle and mast cells. In the coronary artery, mast cells are known to exist in the adventitia, and are assumed to be one of the inducers of medial smooth muscle spasm in response to physiological stress, such as coldness and fatigue, causing transient chest pain (Laine et al., 1999; Laine et al., 2000) . CADM1 may play particular roles in such conditions by mediating both nerve-mast cell and smooth muscle-mast cell interactions. Further characterization of CADM1 functions under physiological and pathological conditions will lead us to future development of novel therapeutic strategies against a variety of neuroimmunerelated and smooth muscle-involved diseases.
